Buzz On The Street

“Buzz on the Street” Show: Stock Market Report (NYSE: CRM RH WORK) (NASDAQ: EXPE)

Salesforce.com, Inc. (NYSE: CRM) released its third quarter results on Tuesday evening, surpassing revenue and earnings, yet still trended downwards as its largest ever acquisition handed the company a net loss for the quarter, and an EPS of 75 cents and revenues of 4.5 billion dollars were not enough to appease investors. Then the Expedia […]

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Eltoprazine & CBD to Treat Parkinson’s

Amarantus Bioscience Holdings, Inc. (OTC: AMBS) (“Amarantus,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary Elto Pharma, Inc. has received a notice of allowance from the European Patent Office (EPO) covering the use of eltoprazine and eltoprazine […]

“Buzz on the Street” Show: Pasha Brands (CSE: CRFT) (OTC: CRFTF) Unveils Craft Labs

Pasha Brands Ltd. (CSE: CRFT) (OTC: CRFTF) (FSE: ZZD), North America’s largest craft cannabis brand house, is pleased to announce the launch of Craft Labs™, a revolutionary digital platform uniquely positioned as the industry’s first complete testing solution, supporting both micro-cultivators and analytical laboratories. Based in Vancouver, British Columbia, Pasha Brands is a vertically integrated […]

“Buzz on the Street” Show: Q BioMed (OTCQB: QBIO) Mannin Research Reports Data: Acute Kidney Injury

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The data was presented at the American Society for Nephrology 2019 Annual Meeting held in Washington DC. Q BioMed Inc. […]

“Buzz on the Street” Show: Nov. 25, 2019 Earnings Focus for the Week (NYSE: PANW BBY) (NASDAQ: NTNX)

Palo Alto Networks, Inc. (NYSE: PANW) will report its fiscal year 2020 first quarter results after the market closes Monday, with analysts expecting an EPS of $1.03 cents on sales of $768 million dollars Concurrently, Nutanix, Inc. (NASDAQ: NTNX) will also release its first quarter results as analysts expect a loss per share of 75 […]

“Buzz on the Street” Show: NewLeaf Brands (CSE: NLB) (OTC: NLBIF) LOI to Acquire Vida Concepts

NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) is pleased to announce that it has entered into a letter of intent (the “LOI”) with an arm’s length-party, Vida Concepts, LLC (“Vida”) and its wholly-owned subsidiary NXTGEN CBD Supplements, LLC (“NXTGEN”), pursuant to which the Company has agreed to acquire 100% of the issued and […]

“Buzz on the Street” Show: Stock Market Retail Report (NYSE: KSS TGT LB) (NASDAQ: URBN)

Kohl’s Corporation (NYSE: KSS) shares tanked by more than 16% on Tuesday after the Company reduced its outlook and missed analyst expectations with earnings of 0.74 cents on revenues of $4.36 billion Then, Urban Outfitters, Inc. (NASDAQ: URBN) slumped more than 14% on Wednesday after it reported earnings of 56 cents per share and revenues […]

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Patent to Treat Retinal Disorders

Amarantus Bioscience Holdings, Inc. (OTC: AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary MANF Therapeutics has been issued a Chinese patent covering the use of mesencephalic astrocyte-derived neurotrophic factor (MANF) and/or cerebral dopamine neurotrophic factor (CDNF) for the […]

“Buzz on the Street” Show: NewLeaf Brands (CSE: NLB) (OTC: NLBIF) We Are Kured Signs LOI with DPAC

NewLeaf Brands Inc.’s (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) wholly owned subsidiary We Are Kured, LLC, announces that it has entered into a letter of intent with Denver based marijuana infused product license holder, Denver Packaging Company, to enter the Colorado cannabis market in 2020. DPAC is the license holder that manufactures renowned brands such […]

“Buzz on the Street” Show: Q BioMed Inc. (OTCQB: QBIO) Announces FDA Approval

Q BioMed Inc. (OTCQB: QBIO), announces FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG). ITG is now cleared to manufacture the Company’s FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP. Q BioMed Inc. is a biotech acceleration and commercial stage company. We are focused on licensing and acquiring undervalued biomedical assets […]